Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Quantum Si Inc QSIAW


Primary Symbol: QSI

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company offers Platinum NGPS instrument that provides single molecule amino acid level resolution with a streamlined workflow, including automated data analysis that accessible to researchers in all laboratory types; Platinum... see more

Recent & Breaking News (NDAQ:QSI)

Quantum-Si Highlights Significant Development Advancements for Proteus(TM) and Industry Leading Technology Pipeline at Investor & Analyst Day

Business Wire November 20, 2025

Quantum-Si to Highlight Significant Proteus(TM) Platform Development Progress and Provide Insights into the Company's Industry Leading Technology Pipeline at Investor & Analyst Day

Business Wire November 19, 2025

Quantum-Si Reports Third Quarter 2025 Financial Results

Business Wire November 5, 2025

Quantum-Si to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Business Wire October 20, 2025

Quantum-Si to Report Third Quarter 2025 Financial Results on November 5, 2025

Business Wire October 13, 2025

Quantum-Si to Host Investor & Analyst Event in New York City on November 19, 2025

Business Wire September 23, 2025

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire September 15, 2025

Quantum-Si Announces the Launch of V4 Sequencing Kit, Expanding Proteome Coverage and Unlocking New Applications for Protein Sequencing

Business Wire September 8, 2025

Quantum-Si to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Business Wire August 19, 2025

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire August 13, 2025

Quantum-Si to Participate in the UBS Precision Medicine Frontiers Summit

Business Wire August 8, 2025

Quantum-Si Reports Second Quarter 2025 Financial Results

Business Wire August 5, 2025

Quantum-Si to Participate in the Canaccord Genuity 45th Annual Growth Conference

Business Wire July 21, 2025

Quantum-Si to Report Second Quarter 2025 Financial Results on August 5, 2025

Business Wire July 14, 2025

Quantum-Si Incorporated Announces Pricing of $50 Million Registered Direct Offering of Common Stock

Business Wire July 3, 2025

Quantum-Si Platinum® Pro Instrument Placed at the Broad Institute to Support Regional Research Initiatives

Business Wire June 24, 2025

Quantum-Si to Join Leading Experts from DNAnexus, Olink, and Northwestern in Upcoming GenomeWeb Webinar on Proteomics Data Integration and Standardization

Business Wire June 19, 2025

Quantum-Si Customer to Showcase Protein Barcoding for Nucleic Acid-LNP Therapeutic Development at Festival of Genomics Boston

Business Wire June 17, 2025

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire June 13, 2025

Quantum-Si's Single-Molecule Tech Enables Precise, Multiplexed Measurement of Nanobody Binding in a Single Assay

Business Wire June 10, 2025